Equivalence of Ina, an AI-based nutrition platform, to human dietitians for counseling patients with cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...
Several biomarkers identified by comprehensive genomic profiling were found to predict efficacy and toxicity of chemo-radiotherapy in patients with non–small cell lung cancer (NSCLC), with progression ...
First-line serplulimab and bevacizumab combined with nab-paclitaxel/gemcitabine followed by mFOLFOX in advanced pancreatic cancer: A phase II trial. This is an ASCO ...